Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Samid

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Cytokine|July 1, 1995
Transcriptional upregulation of TGF-alpha by phenylacetate and phenylbutyrate is associated with differentiation of human melanoma cellsL Liu, W R Hudgins, A C Miller, et al.
International Journal of Cancer|January 21, 1993
Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylationA C Miller, K Kariko, C E Myers, et al.
Cancer Research|October 15, 1993
Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic miceO Berlin, D Samid, R Donthineni-Rao, et al.
Progress in Clinical and Biological Research|January 1, 1985
Mechanisms of antioncogenic activity of interferonD Samid, D M Flessate, J J Greene, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducersD Samid, W R Hudgins, S Shack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Peroxisome proliferator-activated receptor gamma as a novel target in cancer therapy: binding and activation by an aromatic fatty acid with clinical antitumor activityD Samid, M Wells, M E Greene, et al.
Molecular and Cellular Biology|November 1, 1995
Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucialK D Robertson, S D Hayward, P D Ling, et al.
Molecular Pharmacology|June 1, 1996
Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogeneR Danesi, D Nardini, F Basolo, et al.
International Journal of Cancer|February 8, 1995
Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cellsN Sidell, R Wada, G Han, et al.
Therapeutic Drug Monitoring|December 1, 1996
Plasma protein binding of phenylacetate and phenylbutyrate, two novel antineoplastic agentsS Boudoulas, R M Lush, N A McCall, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Cytokine|July 1, 1995
Transcriptional upregulation of TGF-alpha by phenylacetate and phenylbutyrate is associated with differentiation of human melanoma cellsL Liu, W R Hudgins, A C Miller, et al.
International Journal of Cancer|January 21, 1993
Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylationA C Miller, K Kariko, C E Myers, et al.
Cancer Research|October 15, 1993
Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic miceO Berlin, D Samid, R Donthineni-Rao, et al.
Progress in Clinical and Biological Research|January 1, 1985
Mechanisms of antioncogenic activity of interferonD Samid, D M Flessate, J J Greene, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducersD Samid, W R Hudgins, S Shack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Peroxisome proliferator-activated receptor gamma as a novel target in cancer therapy: binding and activation by an aromatic fatty acid with clinical antitumor activityD Samid, M Wells, M E Greene, et al.
Molecular and Cellular Biology|November 1, 1995
Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucialK D Robertson, S D Hayward, P D Ling, et al.
Molecular Pharmacology|June 1, 1996
Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogeneR Danesi, D Nardini, F Basolo, et al.
International Journal of Cancer|February 8, 1995
Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cellsN Sidell, R Wada, G Han, et al.
Therapeutic Drug Monitoring|December 1, 1996
Plasma protein binding of phenylacetate and phenylbutyrate, two novel antineoplastic agentsS Boudoulas, R M Lush, N A McCall, et al.
Pageof 7